Biotech Values

[DewDiligence]

MATK CEO, Pete Linsert, to retire in June

This might be just the impetus I need to consider MATK more seriously. I’ve always thought that MATK’s top management was bush league because they seem to have a crisis just about every quarter. The CEO in particular has struck me as someone with a chip and a propensity to engage in actions that are counter-productive.

On today’s CC, for instance, the CEO got into a shouting match with the analyst from Merrill Lynch over whether the analyst’s phone calls had been returned! It was a spat that the CEO himself invited by chiding the analyst for not devoting more effort to the company.